1. Home
  2. AFYA vs SANA Comparison

AFYA vs SANA Comparison

Compare AFYA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

N/A

Current Price

$15.01

Market Cap

1.4B

Sector

Real Estate

ML Signal

N/A

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$3.55

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AFYA
SANA
Founded
1999
2018
Country
Brazil
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
AFYA
SANA
Price
$15.01
$3.55
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$17.25
$7.83
AVG Volume (30 Days)
134.7K
2.5M
Earning Date
03-12-2026
03-16-2026
Dividend Yield
1.55%
N/A
EPS Growth
25.39
N/A
EPS
1.50
N/A
Revenue
$681,742,784.00
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$7.73
N/A
P/E Ratio
$10.00
N/A
Revenue Growth
14.07
N/A
52 Week Low
$13.12
$1.26
52 Week High
$19.90
$6.55

Technical Indicators

Market Signals
Indicator
AFYA
SANA
Relative Strength Index (RSI) 54.76 36.71
Support Level $13.34 $3.53
Resistance Level $15.46 $4.69
Average True Range (ATR) 0.43 0.34
MACD 0.05 -0.13
Stochastic Oscillator 80.66 13.77

Price Performance

Historical Comparison
AFYA
SANA

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: